• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种能阻断1型人类免疫缺陷病毒糖蛋白41介导的细胞融合的肽抑制剂的设计。

Design of a peptide inhibitor that blocks the cell fusion mediated by glycoprotein 41 of human immunodeficiency virus type 1.

作者信息

Jin B S, Ryu J R, Ahn K, Yu Y G

机构信息

Structural Biology Center, Korea Institute of Science and Technology, Cheongryang, Seoul, South Korea.

出版信息

AIDS Res Hum Retroviruses. 2000 Nov 20;16(17):1797-804. doi: 10.1089/08892220050195757.

DOI:10.1089/08892220050195757
PMID:11118065
Abstract

Fusion between the envelope of HIV and the plasma membrane of target cells is mediated by gp41, the envelope glycoprotein of HIV. Peptides derived from the membrane-proximal helical motif of the extracellular domain of gp41 effectively inhibit the infection of HIV, and their inhibitory activities are known to be correlated with the helical propensity of the peptides. We have designed small peptides that can form a stable alpha helix and thereby inhibit gp120/41-mediated cell fusion. A 19-mer peptide from the membrane-proximal helical motif of gp41 had no secondary structure in solution, and failed to block gp41-mediated cell fusion. When amino acids with low helical propensity were substituted, and helix-capping sequences were introduced at both ends of the peptides, the modified peptides formed a stable helical structure. They also bound to the coiled-coil motif of gp41 presented at the C terminus of thioredoxin and blocked the cell fusion mediated by gp120/41. These results implied that such modification was enough to change a short peptide derived from gp41 into a potent inhibitor against the infection of HIV.

摘要

HIV包膜与靶细胞的质膜之间的融合由HIV包膜糖蛋白gp41介导。源自gp41胞外结构域膜近端螺旋基序的肽可有效抑制HIV感染,且已知其抑制活性与肽的螺旋倾向相关。我们设计了能够形成稳定α螺旋从而抑制gp120/41介导的细胞融合的小肽。来自gp41膜近端螺旋基序的19聚体肽在溶液中没有二级结构,无法阻断gp41介导的细胞融合。当替换螺旋倾向低的氨基酸,并在肽的两端引入螺旋封端序列时,修饰后的肽形成了稳定的螺旋结构。它们还与硫氧还蛋白C端呈现的gp41的卷曲螺旋基序结合,并阻断了gp120/41介导的细胞融合。这些结果表明,这种修饰足以将源自gp41的短肽转变为抗HIV感染的有效抑制剂。

相似文献

1
Design of a peptide inhibitor that blocks the cell fusion mediated by glycoprotein 41 of human immunodeficiency virus type 1.一种能阻断1型人类免疫缺陷病毒糖蛋白41介导的细胞融合的肽抑制剂的设计。
AIDS Res Hum Retroviruses. 2000 Nov 20;16(17):1797-804. doi: 10.1089/08892220050195757.
2
Protein design of a bacterially expressed HIV-1 gp41 fusion inhibitor.一种细菌表达的HIV-1 gp41融合抑制剂的蛋白质设计
Biochemistry. 2007 Apr 10;46(14):4360-9. doi: 10.1021/bi7001289. Epub 2007 Mar 20.
3
Membrane-perturbing domains of HIV type 1 glycoprotein 41.1型人类免疫缺陷病毒糖蛋白41的膜扰动结构域
AIDS Res Hum Retroviruses. 2001 Mar 1;17(4):311-27. doi: 10.1089/08892220150503681.
4
Design of potent inhibitors of HIV-1 entry from the gp41 N-peptide region.基于gp41 N端肽区域设计高效的HIV-1进入抑制剂
Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11187-92. doi: 10.1073/pnas.201392898.
5
Effect of nonpolar substitutions of the conserved Phe11 in the fusion peptide of HIV-1 gp41 on its function, structure, and organization in membranes.HIV-1 gp41融合肽中保守的苯丙氨酸11的非极性取代对其功能、结构及在膜中的组织形式的影响
Biochemistry. 1999 Aug 31;38(35):11359-71. doi: 10.1021/bi990232e.
6
Selection of gp41-mediated HIV-1 cell entry inhibitors from biased combinatorial libraries of non-natural binding elements.从非天然结合元件的偏向组合文库中筛选gp41介导的HIV-1细胞进入抑制剂。
Nat Struct Biol. 1999 Oct;6(10):953-60. doi: 10.1038/13324.
7
Role of the fusion peptide and membrane-proximal domain in HIV-1 envelope glycoprotein-mediated membrane fusion.融合肽和膜近端结构域在HIV-1包膜糖蛋白介导的膜融合中的作用。
Biochemistry. 2003 Dec 9;42(48):14150-8. doi: 10.1021/bi035154g.
8
Differential inhibition of HIV-1 and SIV envelope-mediated cell fusion by C34 peptides derived from the C-terminal heptad repeat of gp41 from diverse strains of HIV-1, HIV-2, and SIV.源自HIV-1、HIV-2和SIV不同毒株gp41 C末端七肽重复序列的C34肽对HIV-1和SIV包膜介导的细胞融合的差异抑制作用
J Med Chem. 2005 Apr 21;48(8):3036-44. doi: 10.1021/jm049026h.
9
Peptide P5 (residues 628-683), comprising the entire membrane proximal region of HIV-1 gp41 and its calcium-binding site, is a potent inhibitor of HIV-1 infection.肽P5(628 - 683位氨基酸残基)包含HIV-1 gp41的整个膜近端区域及其钙结合位点,是一种有效的HIV-1感染抑制剂。
Retrovirology. 2008 Oct 16;5:93. doi: 10.1186/1742-4690-5-93.
10
Fusion peptides derived from the HIV type 1 glycoprotein 41 associate within phospholipid membranes and inhibit cell-cell Fusion. Structure-function study.源自1型人类免疫缺陷病毒糖蛋白41的融合肽在磷脂膜内缔合并抑制细胞间融合。结构-功能研究。
J Biol Chem. 1997 May 23;272(21):13496-505. doi: 10.1074/jbc.272.21.13496.

引用本文的文献

1
HIPdb: a database of experimentally validated HIV inhibiting peptides.HIPdb:一个经实验验证的 HIV 抑制肽数据库。
PLoS One. 2013;8(1):e54908. doi: 10.1371/journal.pone.0054908. Epub 2013 Jan 24.
2
Protease-resistant peptide design-empowering nature's fragile warriors against HIV.设计抗蛋白酶肽——赋予大自然脆弱的战士对抗 HIV 的能力。
Biopolymers. 2012;98(5):431-42. doi: 10.1002/bip.22073.
3
Design of a potent D-peptide HIV-1 entry inhibitor with a strong barrier to resistance.设计一种强效的 D-肽 HIV-1 进入抑制剂,具有很强的抗耐药性。
J Virol. 2010 Nov;84(21):11235-44. doi: 10.1128/JVI.01339-10. Epub 2010 Aug 18.
4
Identification of a beta3-peptide HIV fusion inhibitor with improved potency in live cells.一种在活细胞中效力增强的β3肽HIV融合抑制剂的鉴定。
Bioorg Med Chem Lett. 2009 Jul 15;19(14):3736-8. doi: 10.1016/j.bmcl.2009.05.032. Epub 2009 May 15.
5
Interaction of short modified peptides deriving from glycoprotein gp36 of feline immunodeficiency virus with phospholipid membranes.源自猫免疫缺陷病毒糖蛋白gp36的短修饰肽与磷脂膜的相互作用。
Eur Biophys J. 2009 Sep;38(7):873-82. doi: 10.1007/s00249-009-0454-9. Epub 2009 May 5.
6
Peptide P5 (residues 628-683), comprising the entire membrane proximal region of HIV-1 gp41 and its calcium-binding site, is a potent inhibitor of HIV-1 infection.肽P5(628 - 683位氨基酸残基)包含HIV-1 gp41的整个膜近端区域及其钙结合位点,是一种有效的HIV-1感染抑制剂。
Retrovirology. 2008 Oct 16;5:93. doi: 10.1186/1742-4690-5-93.
7
Potent D-peptide inhibitors of HIV-1 entry.强效的HIV-1进入的D肽抑制剂。
Proc Natl Acad Sci U S A. 2007 Oct 23;104(43):16828-33. doi: 10.1073/pnas.0708109104. Epub 2007 Oct 17.
8
Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus.具有抗恩夫韦肽耐药病毒活性的螺旋寡聚HIV-1融合抑制剂肽的设计
Proc Natl Acad Sci U S A. 2007 Jul 31;104(31):12772-7. doi: 10.1073/pnas.0701478104. Epub 2007 Jul 19.
9
Inhibiting HIV fusion with a beta-peptide foldamer.用β-肽折叠体抑制HIV融合
J Am Chem Soc. 2005 Sep 28;127(38):13126-7. doi: 10.1021/ja053444+.
10
Determinants of human immunodeficiency virus type 1 baseline susceptibility to the fusion inhibitors enfuvirtide and T-649 reside outside the peptide interaction site.人类免疫缺陷病毒1型对融合抑制剂恩夫韦肽和T-649基线易感性的决定因素位于肽相互作用位点之外。
J Virol. 2004 Jul;78(14):7582-9. doi: 10.1128/JVI.78.14.7582-7589.2004.